What's New In Investments, Funds? - AlphaMaven, Revelation Partners

Editorial Staff

16 March 2021

AlphaMaven
, an investor in healthcare, has held the first and final closing of its newest fund, Revelation Healthcare Fund III, at its hard cap of $350 million. The offering was oversubscribed, beating the $300 million initial target.

The firm, which now manages over $900 million of committed capital, specializes in providing shareholder liquidity, general partner solutions, and growth capital for private healthcare companies and investors. It invests across all healthcare sub-sectors, including medical devices, diagnostics, biotech, healthcare technology and healthcare services.

Separately, the firm also announced three recent appointments: Fred Lee, promoted to managing director; Doug Fisher, appointed to venture partner; Suchira Sharma, appointed to associate.

Lee joined Revelation Partners in 2018.

Dr Fisher joins the firm as a venture partner. Since 2009, he has been a member of the healthcare team at InterWest Partners as a partner and executive-in-residence, where he has focused on biopharma, diagnostics, and medical device investing.

Sharma joins from Hercules Capital where she worked as a senior analyst, underwriting and structuring multi-asset transactions for companies focused in clinical-stage biotechnology, specialty pharmaceuticals, medical devices and healthcare technology.